128 related articles for article (PubMed ID: 1530365)
1. Role of testosterone and dihydrotestosterone in spontaneous gynecomastia of adolescents.
Villalpando S; Mondragón L; Barrón C; Pérez-Pastén E; Castañeda G; Alonso-Uriarte R; Cortés-Gallegos V
Arch Androl; 1992; 28(3):171-6. PubMed ID: 1530365
[TBL] [Abstract][Full Text] [Related]
2. Treatment of persistent pubertal gynecomastia with dihydrotestosterone heptanoate.
Eberle AJ; Sparrow JT; Keenan BS
J Pediatr; 1986 Jul; 109(1):144-9. PubMed ID: 3088241
[TBL] [Abstract][Full Text] [Related]
3. The relationship of concentrations of serum hormones to pubertal gynecomastia.
Lee PA
J Pediatr; 1975 Feb; 86(2):212-5. PubMed ID: 1111683
[TBL] [Abstract][Full Text] [Related]
4. Leptin levels in boys with pubertal gynecomastia.
Dundar B; Dundar N; Erci T; Bober E; Büyükgebiz A
J Pediatr Endocrinol Metab; 2005 Oct; 18(10):929-34. PubMed ID: 16355805
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
Cochran RC; Ewing LL; Niswender GD
Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
[TBL] [Abstract][Full Text] [Related]
6. Effects of tamoxifen on the levels of luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL), 17 beta-oestradiol (E2), total and free testosterone (T) and total and free dihydrotestosterone (DHT) in blood of patients with benign prostatic hyperplasia.
Stahl F; Schnorr D; Rohde W; Poppe I; Geier T; Dörner G
Exp Clin Endocrinol; 1983 Jul; 82(1):21-8. PubMed ID: 6193975
[TBL] [Abstract][Full Text] [Related]
7. Studies on the treatment of idiopathic gynaecomastia with percutaneous dihydrotestosterone.
Kuhn JM; Roca R; Laudat MH; Rieu M; Luton JP; Bricaire H
Clin Endocrinol (Oxf); 1983 Oct; 19(4):513-20. PubMed ID: 6354523
[TBL] [Abstract][Full Text] [Related]
8. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of pituitary and testicular hormones of fertile and infertile men.
Stanwell-Smith R; Thompson SG; Haines AP; Jeffcoate SL; Hendry WF
Clin Reprod Fertil; 1985 Mar; 3(1):37-48. PubMed ID: 3919915
[TBL] [Abstract][Full Text] [Related]
10. A Longitudinal Study of Growth, Sex Steroids, and IGF-1 in Boys With Physiological Gynecomastia.
Mieritz MG; Rakêt LL; Hagen CP; Nielsen JE; Talman ML; Petersen JH; Sommer SH; Main KM; Jørgensen N; Juul A
J Clin Endocrinol Metab; 2015 Oct; 100(10):3752-9. PubMed ID: 26287961
[TBL] [Abstract][Full Text] [Related]
11. [Phenotype of patients with gynecomastia].
Czajka-Oraniec I; Zgliczyński W
Endokrynol Pol; 2008; 59(2):131-9. PubMed ID: 18465688
[TBL] [Abstract][Full Text] [Related]
12. [Hormonal profile of idiopathic gynecomastia in young adults. Apropos of 488 cases].
Bauduceau B; Reboul P; Le Guyadec T; Legrelle M; Mayaudon H; Gautier D
Ann Endocrinol (Paris); 1993; 54(3):163-7. PubMed ID: 8024242
[TBL] [Abstract][Full Text] [Related]
13. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty.
Keenan BS; Richards GE; Ponder SW; Dallas JS; Nagamani M; Smith ER
J Clin Endocrinol Metab; 1993 Apr; 76(4):996-1001. PubMed ID: 8473416
[TBL] [Abstract][Full Text] [Related]
14. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels.
Andersson AM; Juul A; Petersen JH; Müller J; Groome NP; Skakkebaek NE
J Clin Endocrinol Metab; 1997 Dec; 82(12):3976-81. PubMed ID: 9398699
[TBL] [Abstract][Full Text] [Related]
15. [Persistant pubertal gynecomastia. Biological study (author's transl)].
Sultan C; Bressot N; Garandeau P; Descomps B; Jean R
Sem Hop; 1980 Dec 8-15; 56(45-46):1923-30. PubMed ID: 6256903
[TBL] [Abstract][Full Text] [Related]
16. The relationship between pubertal gynecomastia, prostate specific antigen, free androgen index, SHBG and sex steroids.
Kilic M; Kanbur N; Derman O; Akgül S; Kutluk T
J Pediatr Endocrinol Metab; 2011; 24(1-2):61-7. PubMed ID: 21528817
[TBL] [Abstract][Full Text] [Related]
17. Gynecomastia as a familial incomplete male pseudohermaphroditism type 1: a limited androgen resistance syndrome.
Larrea F; Benavides G; Scaglia H; Kofman-Alfaro S; Ferrusca E; Medina M; Pérez-Palacios G
J Clin Endocrinol Metab; 1978 Jun; 46(6):961-70. PubMed ID: 122442
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of the binding capacity of plasma sex hormone binding globulin (SHBG) for testosterone and dihydrotestosterone during puberty.
Gaidano G; Berta L; Rovero E; Valenzano C; Rosatti P
Clin Chim Acta; 1980 Jan; 100(2):91-7. PubMed ID: 7188684
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum IGF-I, but unaltered sex steroid levels, in healthy boys with pubertal gynaecomastia.
Mieritz MG; Sorensen K; Aksglaede L; Mouritsen A; Hagen CP; Hilsted L; Andersson AM; Juul A
Clin Endocrinol (Oxf); 2014 May; 80(5):691-8. PubMed ID: 24033660
[TBL] [Abstract][Full Text] [Related]
20. Influence of radical prostatectomy on serum hormone levels.
Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
